Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancer

Trial Profile

Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancer

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 May 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Carboplatin
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jan 2012 Planned End Date changed to 1 Feb 2007 as reported by University Hospital Medical Information Network - Japan.
    • 06 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top